HUTCHMED (China) (HCM) Change in Cash (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Change in Cash of $240.2 million for Q2 2021, up 392.01% year-over-year from $48.8 million in Q2 2020, and up 116.52% quarter-over-quarter from $110.9 million in Q1 2021.
HUTCHMED (China) (HCM) Change in Cash (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Change in Cash for 4 consecutive years, with $240.2 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Change in Cash rose 392.01% year-over-year to $240.2 million; the TTM figure through Jun 2021 stood at $280.0 million (up 971.91% YoY), while the FY2025 annual figure was -$86.2 million, up 31.69% from the prior year.
- Change in Cash rose to $240.2 million in Q2 2021 per HCM's latest filing, from $110.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $240.2 million in Q2 2021 and bottomed at -$82.3 million in Q2 2020.
- Historically, Change in Cash has averaged $26.6 million across 4 years, with a median of $7.6 million in 2019.
- Annual changes were most pronounced in 2020 — Change in Cash plunged 1159.26% — and 2021, when it surged 899.31%.
- HUTCHMED (China)'s Change in Cash stood at -$29.6 million in 2018, then soared by 180.17% to $23.7 million in 2019, then plunged by 446.53% to -$82.3 million in 2020, then surged by 392.01% to $240.2 million in 2021.
- Business Quant data shows HCM's Change in Cash at $240.2 million in Q2 2021, $110.9 million in Q1 2021, and -$82.3 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | HUTCHMED (China) | 2.19 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 240.19 Mn |
| Mar 31, 2021 | 110.93 Mn |
| Jun 30, 2020 | -82.26 Mn |
| Mar 31, 2020 | 11.10 Mn |
| Dec 31, 2019 | 23.74 Mn |
| Sep 30, 2019 | 15.31 Mn |
| Jun 30, 2019 | -6.53 Mn |
| Mar 31, 2019 | 4.11 Mn |
| Dec 31, 2018 | -29.61 Mn |
| Sep 30, 2018 | 42.93 Mn |
| Jun 30, 2018 | -2.29 Mn |
| Mar 31, 2018 | -8.36 Mn |